We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+8.42%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$80B
AUM Growth
+$5.37B
Cap. Flow
-$213M
Cap. Flow %
-0.27%
Top 10 Hldgs %
23.95%
Holding
3,773
New
259
Increased
1,520
Reduced
1,671
Closed
192

Sector Composition

Rank Sector Weight
1 Technology 14.33%
2 Healthcare 8.9%
3 Financials 7.71%
4 Consumer Discretionary 6.92%
5 Industrials 6.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADAM
3326
Adamas Trust
ADAM
$917M
$117K ﹤0.01%
11,489
-1,238
-10% -$12.9K
AVTA
3327
DELISTED
Avantax, Inc. Common Stock
AVTA
$117K ﹤0.01%
12,465
-1,905
-13% -$21.1K
ATEC icon
3328
Alphatec Holdings
ATEC
$1.43B
$116K ﹤0.01%
17,506
DTIL icon
3329
Precision BioSciences
DTIL
$210M
$114K ﹤0.01%
+615
New +$122K
PFL
3330
PIMCO Income Strategy Fund
PFL
$390M
$114K ﹤0.01%
11,235
-194
-2% -$1.96K
NL icon
3331
NLI Holdings
NL
$316M
$113K ﹤0.01%
+26,500
New +$95.4K
ADTN icon
3332
Adtran
ADTN
$667M
$112K ﹤0.01%
10,882
-2,625
-19% -$29.7K
PBYI icon
3333
Puma Biotechnology
PBYI
$461M
$111K ﹤0.01%
+11,000
New +$112K
XERS icon
3334
Xeris Biopharma Holdings
XERS
$1.54B
$110K ﹤0.01%
+18,515
New +$74K
JPM icon
3335
CALL
JPMorgan Chase
JPM
$970B
$108K ﹤0.01%
126,300
-10,600
-8% -$1.04M
PNNT
3336
Pennant Park Investment Corp
PNNT
$245M
$108K ﹤0.01%
33,949
+1,762
+5% +$5.9K
TGP
3337
DELISTED
Teekay LNG Partners L.P.
TGP
$107K ﹤0.01%
10,205
-786
-7% -$8.82K
IMMR icon
3338
Immersion
IMMR
$245M
$105K ﹤0.01%
14,925
BKCC
3339
DELISTED
BlackRock Capital Investment Corporation
BKCC
$104K ﹤0.01%
42,535
+8,761
+26% +$23.1K
MFA
3340
MFA Financial
MFA
$926M
$102K ﹤0.01%
9,535
-2,269
-19% -$24.4K
RAD
3341
DELISTED
Rite Aid Corporation
RAD
$102K ﹤0.01%
+10,703
New +$153K
QTNT
3342
DELISTED
Quotient Limited Ordinary Shares
QTNT
$101K ﹤0.01%
490
+55
+13% +$14.2K
LX
3343
LexinFintech Holdings
LX
$241M
$100K ﹤0.01%
14,629
-30,927
-68% -$269K
BRFS
3344
DELISTED
BRF SA
BRFS
$99K ﹤0.01%
30,286
-2,196
-7% -$8.43K
CVU icon
3345
CPI Aerostructures
CVU
$71.8M
$99K ﹤0.01%
37,100
NCV
3346
Virtus Convertible & Income Fund
NCV
$394M
$99K ﹤0.01%
5,412
-44
-0.8% -$824
GOL
3347
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$96K ﹤0.01%
15,750
-5,000
-24% -$35.4K
SIGA icon
3348
SIGA Technologies
SIGA
$206M
$95K ﹤0.01%
+13,800
New +$93.8K
NEM icon
3349
CALL
Newmont
NEM
$126B
$94K ﹤0.01%
31,400
+21,300
+211% +$1.39M
CCLP
3350
DELISTED
CSI Compressco LP
CCLP
$94K ﹤0.01%
105,574
-7,874
-7% -$7.73K

Similar funds

Raymond James & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Raymond James & Associates held 3,773 positions worth $80B, up 7.2% from $74.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2020 filing shows 259 new, 1,520 increased, 1,671 reduced and 192 closed positions. Its largest new stake was Rocket Companies: 405,835 shares worth $8.09M. The largest sale was Apple, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2020 buy was Rocket Companies: 405,835 shares worth $8.09M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2020, an estimated $140M increase.
  • Raymond James & Associates's biggest Q3 2020 reduction was Apple, cutting an estimated $134M.
  • Raymond James & Associates fully exited Invesco Russell 1000 Dynamic Multifactor ETF in Q3 2020, selling an estimated $15.9M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $80B portfolio in Q3 2020.
  • Raymond James & Associates opened 259 new positions and closed 192 in Q3 2020.
  • Raymond James & Associates's portfolio value rose 7.2% quarter-over-quarter to $80B.

Based on Raymond James & Associates's 13F filing for Q3 2020, filed 4 Nov 2020.